Postherpetic neuralgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 40–85 years; gender is not restricted; 2. Meets the diagnostic criteria for PHN, with a pain duration of >=3 months; 3. NRS pain score of >= 6, with poor response to standard pharmacological treatment; 4. Meets the indications for SCS treatment, is willing to participate in the study and has signed an informed consent form; 5. Is able to cooperate with follow-up visits and assessments.
Exclusion criteria
Exclusion criteria: 1. Coagulation disorders, bleeding tendencies, active infections, or sepsis; 2. Skin infections at the injection site, severe spinal deformities, or spinal stenosis; 3. Malignant tumors, severe cardiovascular or cerebrovascular diseases, and hepatic or renal insufficiency; 4. Pregnant or lactating women; 5. Mental illness, cognitive impairment, or inability to cooperate with the investigator; 6. Patients who have received PRF or PRP treatment within the past month; 7. Other conditions deemed unsuitable for enrollment by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients whose pain relief was >=50% after 6 months of treatment (efficacy rate);;NRS pain scores.; | — |
Countries
China
Contacts
Tianjin Medical University General Hospital